MapLight Therapeutics
MPLT
9.09
-0.27
-2.88%
MapLight Therapeutics
US · MPLT
#3723 by market cap
Listed 2025
9.09
-0.27
-2.88%
Live - 5344 symbols - heartbeat 109s ago
· 2026-10-08 10:00
Pre-market
9.06
-3.21%
After-hours
9.36
0.00%
Overnight
9.36
0.00%
- Market cap
- 505.18M
- P/E (TTM)i
- -1.80
- P/Bi
- 1.45
- EPSi
- -3.66
- Div yieldi
- 0.00%
- 52W posi
- 1%
Reader sentiment
Are you bullish or bearish on MPLT?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 9 analysts
Buy
Avg price target
28.50 +213.5%
Price target rangecurrent 9.09
Low13.00
Avg28.50
High43.00
Buy 67%
Hold 33%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Guggenheim | -- | HOLD | -- |
| 2026-08-31 | Needham | -- | BUY | 43.00 |
| 2026-08-17 | Morgan Stanley | -- | HOLD | 21.00 |
| 2026-08-14 | LifeSci Capital | -- | BUY | 37.00 |
| 2026-08-13 | BMO Capital | -- | BUY | 20.00 |
| 2026-08-11 | UBS | -- | HOLD | 13.00 |
| 2026-08-10 | UBS | -- | HOLD | 13.00 |
| 2026-07-28 | Craig-Hallum | -- | BUY | 25.00 |
| 2026-07-28 | Morgan Stanley | -- | HOLD | 21.00 |
| 2026-07-28 | H.C. Wainwright | -- | BUY | 26.00 |
| 2026-07-27 | LifeSci Capital | -- | BUY | 37.00 |
| 2026-07-27 | Needham | -- | BUY | 45.00 |
| 2026-07-24 | CCORF | -- | BUY | 43.00 |
| 2026-07-21 | UBS | -- | BUY | 52.00 |
| 2026-07-14 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-07-10 | Needham | -- | BUY | 45.00 |
| 2026-07-02 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-06-25 | Raymond James | -- | BUY | 46.00 |
| 2026-06-24 | Raymond James | -- | BUY | 46.00 |
| 2026-06-23 | LifeSci Capital | -- | BUY | 45.00 |
| 2026-06-23 | Craig-Hallum | -- | BUY | 40.00 |
| 2026-06-23 | H.C. Wainwright | -- | BUY | 45.00 |
| 2026-06-22 | Morgan Stanley | -- | BUY | 34.00 |
| 2026-06-22 | Needham | -- | BUY | 42.00 |
| 2026-06-22 | H.C. Wainwright | -- | BUY | 45.00 |
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: UBS moved from Buy to Hold on 2026-08-10.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-08-10 | UBS | BUY → HOLD | 13.00 |
| 2026-07-28 | Morgan Stanley | BUY → HOLD | 21.00 |
Quote time 2026-10-08 10:00:31 · For reference only, not investment advice and not tailored to your situation.